Nazarin da ke kewaye da Lupron ko Provenge magani game da cutar prostate metastatic , farawa da farfadowa a wani mataki na farko ya haifar da ingantacciyar haɓakawa na maganin anticancer. Hakazalika, nazarin nazarin tasiri na farawa Taxoter a wani mataki na farko ya nuna irin wannan abu.
An fara Taxotre a Sakamakon Sake
Taxotre ya kasance ci gaba da shan magani don ci gaba, ciwon sankarar rigakafin hormone na tsawon shekaru goma.
FDA ta amince da ita a shekara ta 2004 bayan an tabbatar da shi don tsawanta rayuwa. Kafin samun amincewa da FDA na Taxotre, samfurori kawai na chemotherapeutic (Novantrone, Emcyt, da Velban) sun kasance masu daraja. Alal misali, Novantrone na iya rage ciwo da kuma inganta rayuwar rayuwa. Duk da haka, ba shi da tasiri kan rayuwa. Taxotre ya amince da FDA bayan da manyan gwaje-gwaje biyu suka tabbatar da amfani da rayuwa, duk da haka, adadin yawan ci gaban rayuwa bai kasance ba ne kaɗan, kawai a cikin watanni kadan.
Shekaru da yawa, masana sunyi mamakin lokacin mafi kyau don amfani da Taxoter. Ya kamata a fara bayan juriya na Lupron ya taso ko zai zama mafi inganci don farawa kafin farkon juriya na hormone? Tun bayan binciken farko da aka kai ga amincewa da FDA na Taxotere ya kiyasta tasirinta a cikin mutanen da suka rigaya sunyi tsayayya da Lupron, manufofin da likitoci suka dauka sun hana Taxotere har sai Lupron ya zama m.
Doctors za su damu kamar haka: "Tun da Taxotere yana da sakamako daban-daban, kuma, tun da babu wani tabbaci cewa magani na farko ya fi tasiri, za mu bayar da shawara kawai don farawa Taxotere bayan Lupron ya tsaya aiki."
An san cewa mafi yawan mutanen da ke fama da ciwon karuwan ciwon ƙwayar cuta na ƙarshe sun haifar da juriya na hormone.
Sabili da haka, tun da yake magani a baya ya fi tasiri sosai, zai zama mahimmanci don la'akari da cutar da cutar kafin kwayoyin cututtukan kwayoyin halitta su kara ƙaruwa kuma su juya zuwa cikin clones mai maganin maganin. A cikin shekara ta 2014 da 2015 sakamakon binciken gwaje-gwaje biyu na gwada gwaje-gwajen da aka buga.
Sakamako na Nazarin Binciken
Binciken na farko, CHAARTED (Chemo-hormonal Therapy a kan Juyin Halitta na Androgen Ablation na Ƙwararren Ciwon Cutar Ciwon Ƙwayar cuta), an gabatar da shi a shekara ta 2014 na Kasuwancin Amirka na Clinical Oncology (ASCO) da aka buga a New England Journal of Medicine a shekara ta 2015. Ya nuna cewa ga mutanen da suka kamu da cutar ciwon daji, wadanda suka riga sun ci gaba da zama tare da Lupron, sun inganta rayuwar idan aka kwatanta da mutanen da suka fara Lupron kadai sannan su fara Taxotre lokacin Lupron ya daina aiki. A cikin wannan binciken, rayuwar mutanen da ke tare da Taxotre a lokaci guda kamar yadda Lupron ya kasance watanni 18 ya fi na mutanen da aka fara magance shi tare da Lupron kawai.
Sakamakon wani, irin wannan jarrabawar, wanda ake kira STAMPEDE (Gidajen Lafiya a Advancing ko Metastatic Ciwon Ƙari Ciwon daji: Bayar da Gwajin Harkokin Drug Efficacy), aka gabatar a taron ASCO na shekara ta 2015.
A cikin wannan binciken kusan kusan 3000 da aka gano, wadanda aka ba da sanyinsu, hamsin maza ne aka ba su Taxotre tare da Lupron. An kwatanta rayuwarsu da sauran rabin wadanda aka fara hulɗa da Lupron kadai. Kamar dai a cikin binciken CHAARTED, wannan rukuni na biyu an bi da shi tare da Taxotere bayan Lupron ya tsaya aiki. Har ila yau, kamar yadda jarrabawar CHAARTED ta kasance, mutanen da suka fara Taxotere kafin tsananin juriya sun rayu.
Don haka, yayin da Taxotere ya kasance yanzu sabuwar ka'ida, a kowace rana gudanar da kula da marasa lafiya da ciwon daji, kamar yadda wasu nau'o'in sababbin jiyya (irin su Zytiga, Xtandi, Xofigo, da kuma Jevtana) da aka zaba sau da yawa sun bi wani kyakkyawan magani, sawa, abin kwaikwayo.
Amfani da magunguna daga jerin ko a hade suna akai-akai akan fuska. Kullun na yau da kullum ya ba da ladabi ga, "Ana yin haka ne kullum."
Doctors yi amfani da wannan tunani mai mahimmanci saboda dalilai da dama kuma ba koyaushe suna nazarin "a waje da akwatin", maganin kulawa ba. Duk da haka, musamman ma yanzu da yawancin sababbin jami'o'in suna FDA-yarda, ta yin amfani da jiyya a cikin hanya mai layi na kasa zai iya ƙwarewa akan waɗannan kayan aikin anticancer.